ARCHIMED completed the acquisition of BioVendor Group.

Synopsis

ARCHIMED, a private equity healthcare specialist, completed the acquisition of BioVendor Group, a global integrated diagnostic player. Financial terms were not disclosed.

Principals

target

BIOVENDOR

bidder

ARCHIMED

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

Market Context

Sort

Seller Team (1)

michal kostka

CEO at BIOVENDOR

Manager

target

Deal

n/a

Total Value

Bidder Team (3)

stéphanie du ché

Communications Director at ARCHIMED

Investor

bidder

Deals

£ 682 M

Total Value

andre-michel ballester

Managing Partner at ARCHIMED

Investor

bidder

Deals

£ 1.02 B

Total Value

david lanchner

Founder and Managing Director at Lanchner Communications

PR Consultant

bidder

Deals

£ 1.69 B

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy